Table 6 Analysis of cost per patient (€, 2011)
Non-exposed group | Exposed group | Difference | |
|---|---|---|---|
Base case | |||
Cost of ART during the study period* | 3,017.50 | 2,873.58 | 143.92 |
Cost of AEs during the study period | 0.00 | 230.26 | −230.26 |
Average total cost during the study period | 3,017.50 | 3,103.84 | −86.34 |
Total cost per day | 25.22 | 25.94 | −0.72 |
Alternative scenario | |||
Cost of ART during the study period | 3,017.50 | 2,873.58 | 143.92 |
Cost of AEs during the study period | 0.00 | 230.26 | −230.26 |
Cost of extra follow-up visit during the study period | 0.00 | 345.83 | −345.83 |
Total cost during the study period | 3,017.50 | 3,449.67 | −432.17 |
Total cost per day | 25.22 | 28.83 | −3.61 |